Established Pharmaceutical Clinical Trial Network

This award-winning and highly regarded clinical trial company is a trusted partner to the world’s largest pharmaceutical firms. Headquartered in San Antonio, it operates both embedded trial sites within medical facilities and a dedicated standalone research center, providing unmatched flexibility and access to a diverse participant pool.
With a team of experienced specialists, the company ensures a steady pipeline of trial participants, strengthening its long-term relationships with pharma clients and driving continuous business growth. In 2024, the company generated $5.16 million in revenue, delivering an impressive $1.54 million in adjusted EBITDA.
*****Please do not inquire without previous experience in this industry.
Its proven, scalable model presents an exceptional opportunity for expansion—either by bringing in additional principal investigators or extending operations beyond its current geographic footprint. The CEO maintains a balanced 40-hour workweek while enjoying the flexibility to travel and pursue personal and professional interests, making for a smooth transition for new ownership.
This is a rare opportunity to acquire a thriving, well-established clinical research company with strong financials, an excellent reputation, and significant growth potential.
With the global population aging and a wave of blockbuster drugs losing patent protection, pharmaceutical companies are under increasing pressure to bring new treatments to market. While many clinical trial providers exist, this company stands out with its network-based approach, offering pharma clients a seamless solution for patient recruitment and data collection—all through a single, reliable point of contact. This efficiency, combined with a strong track record of delivering results, positions the company as a preferred partner in a rapidly growing and highly competitive industry.